LITNOF Trademark
LITNOF is a USPTO trademark filed by Glaxo Group Limited. Status: Registered.
Trademark Facts
| Mark | LITNOF |
|---|---|
| Serial Number | 97235596 |
| Registration Number | 6990300 |
| Status | Registered |
| Filing Date | 2022-01-24 |
| Registration Date | 2023-02-28 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Glaxo Group Limited |
| Attorney of Record | Elizabeth K. Rucki |
| Prosecution Events | 17 |
| Latest Event | REAP on 2023-10-06 |
Goods & Services
Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders